Heart surgery patients may get less nausea with higher propofol dose
NCT ID NCT07386379
First seen Feb 04, 2026 · Last updated May 15, 2026 · Updated 14 times
Summary
This study looks at whether giving a higher dose of propofol (a common anesthesia drug) during heart bypass surgery can lower the chance of nausea and vomiting afterward. Researchers will follow 60 adults having planned heart bypass surgery and compare those who get a high dose versus a low dose. The goal is to see if the higher dose helps patients feel better and need less anti-nausea medicine in the first 24 hours after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE NAUSEA AND VOMITING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yasemin Ozsahin
RECRUITINGIstanbul, Outside of the US, 34000, Turkey (Türkiye)
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.